Thomas Spitznagel
Fortune : 160 339 $ au 31/05/2026
Fortune : 160 339 $ au 31/05/2026
Thomas M.
Spitznagel is Senior Vice President-Technical Operations at MacroGenics, Inc. since 2013.
Formerly, Senior Scientist at Nabi Biopharmaceuticals from 1996 to 1998, Vice President-BioPharmaceutical Development at Human Genome Sciences, Inc. from 1998 to 2012, and Staff Engineer at Genetics Institute LLC in 1996.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC. 0,06 % | 15/02/2026 | 38 543 ( 0,06 % ) | 160 339 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MACROGENICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | 01/07/2012 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/1998 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/01/1996 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
MacroGenics, Inc.
MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national